Nonalcoholic fatty liver disease Archives

Pre-Clinical Safety Data Available on DA-1241 Combination for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Post author:Jessica Lynn
Post published:February 9, 2024
Post category:Metabolic dysfunction-associated steatohepatitis Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Metabolic dysfunction-associated steatohepatitis (MASH) unfortunately has no treatments to reverse the disease or its damage. MASH can be managed through weight loss, regular exercise, and blood sugar management. But identifying…

1662222 / Pixabay

Your Risk of Infection and Hospitalization Increases with Each Year of NAFLD

Post author:Jessica Lynn
Post published:July 24, 2023
Post category:Nonalcoholic fatty liver disease

Despite the rising prevalence of nonalcoholic fatty liver disease (NAFLD), there is still a general lack of understanding as to how the condition affects long-term health. According to a publication…

source: pixabay.com

Study of the Week: Investigational Treatment Shows Promise for Treating Nonalcoholic Steatohepatitis

Post author:James Moore
Post published:July 17, 2023
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

source: shutterstock.com

Promising Results in Phase 3 NASH Clinical Trial

Post author:James Moore
Post published:July 7, 2023
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

According to a story from Healio, in a phase 3 clinical trial, treatment with the drug resmetirom was able to achieve the desired endpoints at 52 weeks in people living…

sasint / Pixabay

Bariatric Surgery Could Improve Outcomes for Obese Individuals with NAFLD

Post author:Jessica Lynn
Post published:May 25, 2023
Post category:Nonalcoholic fatty liver disease

Bariatric surgery refers to surgical procedures that can help people with obesity to lose weight when other means have not worked. This type of surgery can help people to live…

source: pixabay.com

Non-Alcoholic Fatty Liver Disease (NAFLD) in Pregnancy has Nearly Tripled in the Past Ten Years

Post author:Rose Duesterwald
Post published:May 16, 2023
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

In the last decade, NAFLD in pregnancy has nearly tripled in concert with the worldwide increase in diabetes. Mayo Clinic reports that NAFLD in general affects one-fourth of the…

Arcaion / Pixabay

ICYMI: Positive Topline Data Available on Pemvidutide for NAFLD

Post author:Jessica Lynn
Post published:February 1, 2023
Post category:Nonalcoholic fatty liver disease

In a late December 2022 news release from biopharmaceutical company Altimmune, Inc., the company shared that positive topline data was available from a 24-week study—including a 12-week extension—which evaluated…

A New Drug With the Potential to Lessen the Demand for Liver Transplants

Post author:Rose Duesterwald
Post published:November 1, 2022
Post category:Liver Research Nonalcoholic fatty liver disease

Dr. Paul Monga, director of Pittsburgh’s Liver Research Center, and his team are studying cancer and liver regeneration. Dr. Monga recently published a study that finds activation of a medication…

source: pixabay.com

Study of the Week: Spermidine Could Play a Role in Treating Nonalcoholic Steatohepatitis

Post author:James Moore
Post published:October 17, 2022
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Editor’s Choice: A Childhood Tragedy, New Findings in NAFLD, And the Start of a Clinical Trial

Post author:James Moore
Post published:August 29, 2022
Post category:Mesenchymal tumor Nonalcoholic fatty liver disease

Happy Monday! This week, we have details on a sad story of a toddler passing away from very rare mesenchymal chondrosarcoma, new research about the genetic risk factors of non-alcoholic…

source: pixabay.com

Study of the Week: Study Reveals New Genetic Risk Factors for Non-Alcoholic Fatty Liver Disease

Post author:James Moore
Post published:August 22, 2022
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

source: pixabay.com

Could Growth Hormone Improve NAFLD Outcomes?

Post author:Jessica Lynn
Post published:August 17, 2022
Post category:Nonalcoholic fatty liver disease

Over the last few years, the incidence of nonalcoholic fatty liver disease (NAFLD) has increased rapidly. As a result, many researchers are beginning to pay closer attention to this disease…

Sourced from Unsplash.com: https://unsplash.com/photos/Iy7QyzOs1bo

Study Explores Genetic Risk Factors for NAFLD

Post author:Jessica Lynn
Post published:August 16, 2022
Post category:Nonalcoholic fatty liver disease

The incidence of nonalcoholic fatty liver disease (NAFLD) has been rapidly rising worldwide, with many healthcare providers expressing concern. Because of this rapid growth – and simultaneous problems with underdiagnosis…

source: pixabay.com

Study of the Week: NAFLD Rates Are Rising Rapidly Around the World

Post author:James Moore
Post published:August 1, 2022
Post category:Nonalcoholic fatty liver disease

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

source: pixabay.com

Study Finds NAFLD Rates Rising on Global Scale

Post author:Jessica Lynn
Post published:July 27, 2022
Post category:Nonalcoholic fatty liver disease

In late June 2022, Patient Worthy discussed how doctors and scientists were concerned about rising rates of nonalcoholic fatty liver disease (NAFLD) in Filipinos. But according to new research, the…

PublicDomainPictures / Pixabay

Rates of NAFLD Rising in Filipinos, Doctors Warn

Post author:Jessica Lynn
Post published:June 24, 2022
Post category:Nonalcoholic fatty liver disease

Altogether, an estimated 15-30% of people around the globe have nonalcoholic fatty liver disease (NAFLD), a condition in those who drink very little or not at all which mimics liver…

A National Survey of NASH Patients Will Provide Insights on Improving Care

Post author:Trudy Horsting
Post published:May 4, 2022
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

The Fatty Liver Foundation (FLF) has just announced a new national survey which will document the experiences and needs of individuals living with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic…

Does Exercise Help with Clotting in NAFLD Patients?

Post author:Kendall Mason
Post published:March 10, 2022
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

A recent study conducted at the Penn State College of Medicine focused in on nonalcoholic fatty liver disease (NAFLD), specifically blood clotting in this rare disorder. These researchers knew that…

source: pixabay.com

Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis

Post author:Rose Duesterwald
Post published:January 14, 2022
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Nonalcoholic steatohepatitis is a liver disease, causing fat to build up in the liver. The resulting inflammation may lead to liver cancer or cirrhosis (scarring) and possible liver failure. As…

Fatty Liver Disease Can be Improved With Lifestyle Changes

Post author:Trudy Horsting
Post published:January 10, 2022
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Fatty Liver Disease This condition is exactly what it sounds like- excess fat accumulates in the liver and causes damage. The condition can have many negative consequences on the body.…

Source: Pexels.com

Low Carbohydrate Diet Helpful in Treating NAFLD

Post author:Alyssa Stevens
Post published:January 6, 2022
Post category:Nonalcoholic fatty liver disease

According to a recent article, a low carbohydrate intervention used to reduce type 2 diabetes and for prediabetes regression, may be a treatment option for patients with nonalcoholic fatty liver…

source: pixabay.com

Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus

Post author:Alyssa Stevens
Post published:December 10, 2021
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

According to a recent article from Physician’s Weekly, two trials recently published are showing the results of striving to improve the management and outcomes in nonalcoholic steatohepatitis (NASH) and…

source: pixabay.com

Study: Understanding the Outcomes of NAFLD and NASH

Post author:Kendall Mason
Post published:October 26, 2021
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Currently, there are no FDA-approved treatments for nonalcoholic fatty liver disease (NAFLD) or its more advanced version: nonalcoholic steatohepatitis (NASH). This is partly due to the lack of understanding surrounding…

source: pixabay.com

First Patient Dosed in Clinical Trial of BOS-580 for NASH

Post author:Kendall Mason
Post published:October 12, 2021
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

The first patient in a Phase 2a trial of BOS-580 as a treatment for nonalcoholic steatohepatitis (NASH) was recently dosed. Boston Pharmaceuticals, the developer of the drug, aims to address…

source: shutterstock

Rare Classroom: Nonalcoholic Fatty Liver Disease

Post author:James Moore
Post published:August 4, 2021
Post category:Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Pre-Clinical Safety Data Available on DA-1241 Combination for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Your Risk of Infection and Hospitalization Increases with Each Year of NAFLD

Study of the Week: Investigational Treatment Shows Promise for Treating Nonalcoholic Steatohepatitis

Promising Results in Phase 3 NASH Clinical Trial

Bariatric Surgery Could Improve Outcomes for Obese Individuals with NAFLD

Non-Alcoholic Fatty Liver Disease (NAFLD) in Pregnancy has Nearly Tripled in the Past Ten Years

ICYMI: Positive Topline Data Available on Pemvidutide for NAFLD

A New Drug With the Potential to Lessen the Demand for Liver Transplants

Study of the Week: Spermidine Could Play a Role in Treating Nonalcoholic Steatohepatitis

Editor’s Choice: A Childhood Tragedy, New Findings in NAFLD, And the Start of a Clinical Trial

Study of the Week: Study Reveals New Genetic Risk Factors for Non-Alcoholic Fatty Liver Disease

Could Growth Hormone Improve NAFLD Outcomes?

Study Explores Genetic Risk Factors for NAFLD

Study of the Week: NAFLD Rates Are Rising Rapidly Around the World

Study Finds NAFLD Rates Rising on Global Scale

Rates of NAFLD Rising in Filipinos, Doctors Warn

A National Survey of NASH Patients Will Provide Insights on Improving Care

Does Exercise Help with Clotting in NAFLD Patients?

Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis

Fatty Liver Disease Can be Improved With Lifestyle Changes

Low Carbohydrate Diet Helpful in Treating NAFLD

Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus

Study: Understanding the Outcomes of NAFLD and NASH

First Patient Dosed in Clinical Trial of BOS-580 for NASH

Rare Classroom: Nonalcoholic Fatty Liver Disease

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

“Shades of Psoriasis”: Plaque Psoriasis and Sharing Your Story

Understanding RSV: Why Combatting Ethnic and Age-Related Health Disparities Could Improve Outcomes

We Need Equity and Diversity Within Rare Disease Research

DNA in Color: How Ronya Nelson is Working to Close the Diversity Gap in Genetics - Part 1

Bridging the Diversity Gap in Healthcare

Congratulations to the 2023 Recipients of the Diversity in Lupus Research Awards!

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

Let’s Work Together!

Keep Up to Date

Learn More